Peptide Checkup

Compound record · Skin, hair & cosmetic

Collagen peptides

Also Hydrolysed collagen · Collagen hydrolysate · Hydrolyzed collagen · Marine collagen · Bovine collagen · Verisol · Peptan · Gelatin

Oral hydrolysed collagen (food supplement)

Skin, hair & cosmeticEvidence · ModerateFood supplement with human trials

Oral food supplement with modest randomised-trial evidence for skin and joints

Check my fitCompare

Record reviewed 1 September 2026 · 6 references

Class
Hydrolysed animal collagen (food supplement)
Trial participants
> 1,700 across 26 randomised skin trials (meta-analysis)
Studied doses
2.5–5 g/day (skin); 10–15 g/day (joints, muscle)
Regulatory status
Food supplement in all major jurisdictions
Anti-doping
Not prohibited

01 Overview

What Collagen peptides is

Summary

Collagen peptides are short chains produced by breaking down animal collagen (bovine, porcine, marine or chicken) so that they dissolve in water and are absorbed after ingestion. Taken at 2.5–15 g per day, they have been tested in dozens of randomised trials and several meta-analyses that report small improvements in skin hydration and elasticity over 8–12 weeks, and limited evidence for activity-related joint pain and body composition. They are regulated as a food, not a medicine, and have a good safety record.

Mechanism

Digestion releases glycine, proline and hydroxyproline together with small bioactive dipeptides (for example prolyl-hydroxyproline) that appear in the blood within an hour and may signal fibroblasts and chondrocytes to synthesise collagen and other matrix proteins. Part of the effect is simply extra protein and collagen-specific amino acids.

Routes studiedOral
Anti-dopingNot prohibited

02 Evidence by goal

What has been shown, for which goal

Grades follow one scale across the site. Moderate overall means: at least one well-conducted randomised trial or consistent controlled human studies.

  1. Skin & cosmetic

    Moderate

    Meta-analyses of 19–26 randomised trials (about 1,100–1,700 participants) report small but consistent improvements in skin hydration and elasticity after 8–12 weeks at 2.5–10 g per day. A 2025 analysis found the effect disappeared in trials without industry funding and in higher-quality studies, so the true effect is probably modest.

  2. Injury & recovery support

    Limited

    A 24-week trial of 10 g per day in 147 athletes reported small reductions in activity-related joint pain; a short crossover study found 15 g of vitamin-C-enriched gelatin before exercise doubled a blood marker of collagen synthesis. No trial has shown faster healing of a diagnosed tendon or ligament injury.

  3. Muscle & recovery

    Limited

    In 53 older men with sarcopenia, 15 g per day alongside 12 weeks of resistance training increased fat-free mass and strength more than placebo. Collagen is an incomplete protein (low in leucine), so it does not replace whey or food protein for muscle building; recovery studies in younger athletes are small and mixed.

  4. Hair

    Limited

    Hair claims rest on a few small, manufacturer-funded trials of multi-ingredient supplements containing collagen; no adequately controlled trial has isolated an effect of collagen peptides on hair growth or thickness.

03 Regulatory status

Where it is authorised, and for what

Status is recorded per jurisdiction from regulator sources and reviewed by hand. It is never inferred from another region's decision.

United Kingdom

Not authorised

Regulated as a food supplement, not a medicine.

Sold legally under the Food Supplements Regulations. Products may not make medicinal claims (for example 'treats arthritis'); no authorised health claims specific to collagen exist in the UK register.

StatusNot authorised
Status last reviewed1 September 2026
SourceOur maintained database — never inferred

04 Dosing research

What the evidence says about exposure

Published human studies and the doses, routes and durations they used — reported as research information, not a recommendation.

Research information — not a recommendation. These are the exposures used in published human studies, reported so you can see what has been tested. They are not dosing instructions and do not apply to any individual.

Study 01

Specific collagen peptides and skin elasticity in women

Proksch E et al., Skin Pharmacol Physiol 2014;27:47–55 · Source

Randomised controlled trial2014
Design
Randomised, double-blind, placebo-controlled, three-arm
Population
Healthy women aged 35–55
Participants
n = 69
Duration
8 weeks (plus 4-week follow-up)
Route
Oral
Doses studied
2.5 g or 5.0 g hydrolysed collagen (bovine, Verisol) once daily, or maltodextrin placebo
Outcome at this exposure
Skin elasticity improved by about 7% versus placebo at 4 and 8 weeks in both dose groups, with no difference between 2.5 g and 5 g; the effect was larger in women over 50. Hydration and roughness changes were not significant.
Adverse events observed
No adverse events attributed to the supplement were reported.

Study 02

Collagen hydrolysate in athletes with activity-related joint pain

Clark KL et al., Curr Med Res Opin 2008;24:1485–1496 · Source

Randomised controlled trial2008
Design
Randomised, double-blind, placebo-controlled
Population
Varsity and club-sport athletes with activity-related joint pain and no diagnosed joint disease
Participants
n = 147
Duration
24 weeks
Route
Oral
Doses studied
10 g collagen hydrolysate in 25 mL liquid once daily, or xanthan placebo
Outcome at this exposure
Among 97 evaluable participants, six of the pain parameters (for example pain when walking: −1.11 vs −0.46 on a 10-point scale) improved significantly more with collagen; effects were larger in the knee-pain subgroup. Differences were small and a third of participants were not evaluable.
Adverse events observed
No safety concerns were identified; the supplement was well tolerated.

Study 03

Collagen peptides with resistance training in older men with sarcopenia

Zdzieblik D et al., Br J Nutr 2015;114:1237–1245

Randomised controlled trial2015
Design
Randomised, double-blind, placebo-controlled
Population
Men aged about 72 with class I or II sarcopenia completing a supervised resistance-training programme
Participants
n = 53
Duration
12 weeks
Route
Oral
Doses studied
15 g collagen peptides (Bodybalance) once daily after training, or silica placebo
Outcome at this exposure
Fat-free mass rose by 4.2 kg versus 2.9 kg with placebo, quadriceps strength by 16.5 versus 7.3 Nm, and fat mass fell by 5.4 versus 3.5 kg — all in addition to the training effect.
Adverse events observed
No adverse events attributed to the supplement were reported.

Most trials used 2.5–5 g per day for skin and 10–15 g per day for joints or muscle, taken for 8–24 weeks. Many were funded by ingredient manufacturers and used their specific products, so results may not transfer to every brand.

05 Safety

Adverse effects and contraindications

Common effects seen in trials or reports, serious effects that warrant urgent review, and conditions under which use is not appropriate or needs assessment.

Common adverse effects

  • Feeling of fullness or bloating
  • Mild nausea or unpleasant aftertaste
  • Heartburn or reflux
  • Loose stools at higher doses

Serious adverse effects

  • Allergic reactions in people allergic to the source (fish, shellfish, bovine, egg)
  • Hypercalcaemia has been reported with some calcium-rich marine or shark-cartilage products
  • Heavy-metal exposure from poorly controlled products (a manufacturing, not a collagen, problem)

Contraindications

  • Kidney diseaseCaution

    Collagen adds 10–15 g of protein per day at the higher doses. People with chronic kidney disease who have been advised to limit protein should check with their kidney team first.

  • Gastrointestinal diseaseCaution

    Generally well tolerated, but fullness, bloating or reflux are the most common complaints; people with active gastrointestinal disease may notice symptoms more.

Do not use = should not be used · Caution = needs assessment

06 Interactions

Medicine classes that need review

Grouped by how seriously the combination should be taken. Class labels match the medicines questionnaire in the assessment.

  • Major
  • Moderate
  • Minor

Minor

Generally compatible; awareness is sufficient.

  • Thyroid hormone

    Levothyroxine, liothyronine

    Levothyroxine should be taken on an empty stomach, separated by several hours from protein or calcium-containing supplements such as some marine collagen products, which can reduce its absorption.

  • Narrow-therapeutic-index medicine

    Lithium, digoxin, ciclosporin

    No specific interactions are documented, but any bulk protein supplement taken at the same time as a medicine that depends on precise absorption is best separated in time.

07 Pregnancy & breastfeeding

Status in pregnancy

Insufficient data

As a food-derived protein, hydrolysed collagen is not expected to pose a specific risk, but supplements have not been formally studied in pregnancy or breastfeeding. Discuss with a midwife or doctor, and prefer products with third-party heavy-metal testing.

08 Monitoring

What is usually monitored

Parameters that trials and product information track. A clinician decides what applies to an individual.

  1. 01Objective before-and-after comparison at 8–12 weeks rather than day-to-day impressions
  2. 02Total daily protein intake, especially if you also use other protein supplements
  3. 03Kidney function if you have kidney disease and are adding protein
  4. 04Allergy symptoms when starting a product from a new animal source
  5. 05Whether joint or skin changes might have a medical cause that deserves assessment

09 Combinations

What is known about combining it

Notes on pairing with other compounds in the directory: whether the combination has been studied in people, and where mechanisms overlap.

  • GHK-Cu

    No human studies

    Overlap · Both are marketed for skin firmness and collagen support.

    Different routes (oral supplement, topical peptide) and low individual risk, but no study has tested the combination.

  • BPC-157

    No human studies

    Overlap · Both are marketed for tendon and ligament healing.

    No data on combined use. Collagen has some human trial evidence for joint pain; BPC-157 has none, so the pairing adds an unregulated injectable to a low-risk food supplement.

  • TB-500

    No human studies

    Overlap · Both are marketed for tissue repair.

    No data on combined use; TB-500 has no human data at all.

  • Semaglutide

    No human studies

    Overlap · Protein intake matters during rapid weight loss to limit lean-mass loss.

    No trial has tested collagen during GLP-1 treatment. Collagen is low in leucine and should not be counted as the main protein source; complete proteins and resistance training are what the evidence supports.

  • Tirzepatide

    No human studies

    Overlap · Protein intake matters during rapid weight loss to limit lean-mass loss.

    No trial has tested collagen during incretin treatment; the same caveat about incomplete protein applies.

Discuss any proposed combination with a qualified healthcare professional.

10 Source considerations

Supply, quality and legitimacy

How the compound reaches people in practice, and what that means for product quality.

  1. 01Choose products with independent third-party testing (for example Informed Sport, NSF or USP) — analyses have found detectable heavy metals in a proportion of collagen powders.
  2. 02Check the source (bovine, porcine, marine, chicken) against allergies and dietary or religious requirements.
  3. 03Trial doses were 2.5–15 g per day; some products deliver only 1–2 g per serving.
  4. 04Claims of 'type I/II/III' specificity or 'medical grade' are marketing terms; hydrolysis largely destroys the original triple-helix structure.

11 Questions for your clinician

Take these to your appointment

Specific to this compound. The personal assessment adds questions drawn from your own history and medicines.

  1. 01Is my skin or joint concern something a supplement could plausibly help, or does it need diagnosis first?
  2. 02Does my kidney function or protein intake make 10–15 g of additional protein a problem?
  3. 03If muscle or recovery is my goal, should I prioritise total protein and leucine intake over collagen specifically?
  4. 04Are there any reasons to avoid a particular collagen source given my allergies or medicines?

The personal assessment tailors this list to your responses.

12 Alternatives

Compounds with stronger evidence or firmer regulatory footing

Listed for overlapping goals. Whether any is appropriate depends on your history — the assessment maps that for you.

13 References

Sources behind this record

Regulator documents and peer-reviewed publications used to derive every grade and statement above.

  1. 01de Miranda RB, Weimer P, Rossi RC. Effects of hydrolyzed collagen supplementation on skin aging: systematic review and meta-analysis. Int J Dermatol 2021;60:1449–1461
  2. 02Pu SY et al. Effects of oral collagen for skin anti-aging: systematic review and meta-analysis. Nutrients 2023;15:2080
  3. 03Effects of collagen supplements on skin aging: meta-analysis by funding source and study quality. Am J Med 2025
  4. 04Proksch E et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology. Skin Pharmacol Physiol 2014;27:47–55
  5. 05Clark KL et al. 24-week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. Curr Med Res Opin 2008;24:1485–1496
  6. 06Zdzieblik D et al. Collagen peptide supplementation in combination with resistance training improves body composition in elderly sarcopenic men. Br J Nutr 2015;114:1237–1245

The Peptide Checkup provides educational information and a structured summary of published research and regulatory status. It is not medical advice, does not diagnose or treat any condition, and does not replace a consultation with a qualified healthcare professional.

Personal assessment

Check Collagen peptides against your history

Seven minutes of structured questions about your goal, history and medicines, mapped against this record by a deterministic, clinician-reviewable rules engine. The report tells you when not to buy.

Start the assessmentCompare with another